Table 6 Relation between GSDMD and VEGF with the response, progression, and outcome among malignant pleural effusion group
From: Role of GSDMD and VEGF in differentiating between malignant and non-malignant pleural effusions
Studied variables | Total no | GSDMD | Test of sig. P value | VEGF | Test of sig. P value |
|---|---|---|---|---|---|
No. (%) | Mean ± SD | Mean ± SD | |||
Response | |||||
Complete response Progressive disease Partial response Stable disease | 3(13.0) 2(8.70) 12(52.2) 6(26.1) | 3.45 ± 0.20 4.97 ± 1.27 4.45 ± 1.83 4.50 ± 1.97 | K 1.79 0.617 | 235.9 ± 33.1 195.7 ± 49.5 258.8 ± 56.5 267.7 ± 36.6 | K 2.89 0.409 |
Progression | U | U | |||
Progressed Not progressed | 18(78.3) 5(21.7) | 4.66 ± 1.79 3.37 ± 0.14 | 1.41 0.157 | 274.9 ± 46.1 217.3 ± 22.3 | 2.47 0.013* |
Outcome | U | U | |||
Alive Dead | 19(82.6) 4(17.4) | 4.39 ± 1.79 4.34 ± 1.05 | 1.13 0.256 | 257.8 ± 50.8 275.5 ± 37.1 | 0.896 0.370 |